Megalestari Epack Sentosaraya Tbk. vs Merck Tbk. — how do they compare? Megalestari Epack Sentosaraya Tbk. trades at Rp69 (market cap 227.93B, 45.42M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Merck Tbk. is far larger — about 7.5× Megalestari Epack Sentosaraya Tbk.'s market cap, and Megalestari Epack Sentosaraya Tbk. is more actively traded (45.42M versus 21.9K). Which is the better fit depends on your goals.
| EPAC | MERK | |
|---|---|---|
Market Cap | 227.93B | 1.7T |
Volume | 45.42M | 21.9K |
Lot | 454.19K | 219 |
Turnover | 3.05B | 83.99M |
Average Price | 67.25 | 3,834.93 |
Value | 3.05B | 83.99M |
Indicative Equilibrium Price | 69 | 3,850 |
Indicative Equilibrium Volume | 325.1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Megalestari Epack Sentosaraya Tbk ("Company") formerly PT Era Prima Adi Cipta Kreasindo and its subsidiaries (together the "Group") was established based on the Deed No.55, dated June 18, 2013 of Poppie Savitri Martosuhardjo Pharmanto, S.H., notary in Jakarta.
Read more on EPAC →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →